| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/02/2023 |
3
| KIRBY J SCOTT (Director) has filed a Form 3 on CVS HEALTH Corp |
| 10/02/2023 |
4
| KIRBY J SCOTT (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 299 shares
@ $69.82, valued at
$20.9k
|
|
| 08/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/17/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 08/04/2023 |
4
| Clark James David (SVP, Cont & Chief Acct Officer) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Sold 2,631 shares
@ $74.79, valued at
$196.8k
Sold 23,128 shares
@ $74.94, valued at
$1.7M
|
|
| 08/04/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
8-K
| Quarterly results |
| 06/01/2023 |
424B2
| Form 424B2 - Prospectus [Rule 424(b)(2)]: |
| 05/31/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 05/30/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 05/25/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 05/24/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/19/2023 |
4
| MILLON JEAN PIERRE (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 shares
@ $69.31, valued at
$99.6k
|
|
| 05/19/2023 |
4
| Finucane Anne A. (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 shares
@ $69.31, valued at
$99.6k
|
|
| 05/19/2023 |
4
| DEPARLE NANCY ANN (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 shares
@ $69.31, valued at
$99.6k
|
|
| 05/19/2023 |
4
| Balser Jeffrey R. (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 shares
@ $69.31, valued at
$92.1k
|
|
| 05/19/2023 |
4
| AGUIRRE FERNANDO (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 shares
@ $69.31, valued at
$92.1k
|
|
| 05/19/2023 |
4
| SCHAPIRO MARY L (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 options to buy
@ $0 |
|
| 05/19/2023 |
4
| LUDWIG EDWARD J (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 2,069 options to buy
@ $0 |
|
| 05/19/2023 |
4
| FARAH ROGER N (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 3,917 options to buy
@ $0 |
|
| 05/19/2023 |
4
| BROWN C DAVID II (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,437 options to buy
@ $0 |
|
| 05/19/2023 |
4
| DECOUDREAUX ALECIA A (Director) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 1,329 options to buy
@ $0 |
|
| 05/05/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
8-K
| Quarterly results |
| 05/02/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 04/26/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
|